Union Home Minister Amit Shah recently laid the foundation stone for India’s first state-funded Bio-Safety Level 4 (BSL-4) containment facility in Gandhinagar, Gujarat. He referred to this laboratory as a “health shield” for the nation, indicating a transformative step in India’s health security and biotechnology capabilities.
A Bio-Safety Level 4 (BSL-4) facility is designed to handle the most dangerous and highly infectious pathogens, many of which currently have no effective vaccines or treatments. These laboratories operate under stringent international safety standards, enabling advanced research on deadly diseases. This includes the development of diagnostics, vaccines, therapeutics, and rapid outbreak response strategies.
The upcoming BSL-4 laboratory in Gandhinagar, alongside an Animal Bio-Safety Level (ABSL) facility, will serve as a strategic national asset for researching some of the deadliest known pathogens. It will significantly enhance the country's health security and bio-preparedness.
This facility, developed under the Gujarat State Biotechnology Mission, spans 11,000 square meters with a budget of ₹362 crore. It is noteworthy as India’s first fully state-funded and state-controlled BSL-4 facility and the second civilian BSL-4 lab in the country.
The facility will function under the Gujarat Biotechnology Research Centre, which already manages a BSL-2+ laboratory. This center played a crucial role during the Covid-19 pandemic by sequencing the SARS-CoV-2 genome. Planning for the BSL-4 lab commenced in mid-2022, with the foundation stone laid on January 13, 2026.
The complex will comprise multiple laboratory modules, including BSL-4, BSL-3, BSL-2, ABSL-4, and ABSL-3, along with advanced utilities and support systems. The development adheres to international biosafety guidelines established by the Centers for Disease Control and Prevention, National Institutes of Health, Department of Biotechnology, and the Indian Council of Medical Research.
This lab will enhance Gujarat’s and India’s capacity to respond effectively to outbreaks of deadly human diseases and zoonotic infections. It will facilitate advanced research into diagnostics, vaccines, and therapeutics. The ABSL-4 component will enable animal disease research and vaccine production using antibodies derived from animals, which previously required samples to be sent to ICAR-National Institute of High Security Animal Diseases.
The Department of Biotechnology has signed a memorandum of understanding (MoU) designating the lab as a national facility, ensuring oversight from expert institutions across India. Officials emphasize that this lab will eliminate long-standing bottlenecks caused by inadequate BSL-4 infrastructure in the country.
Currently, India has one operational civilian BSL-4 laboratory at the National Institute of Virology in Pune, Maharashtra, which conducts research on the most dangerous human pathogens. Additionally, the Defence Research and Development Organisation established a BSL-4 laboratory in Gwalior in late 2024, expanding India’s high-containment research capacity.
Globally, approximately 69 BSL-4 laboratories are operational or under development, highlighting India's relatively limited but gradually expanding presence in high-containment biological research infrastructure. As of March 2025, the Ministry of Health and Family Welfare has approved 165 biosafety laboratories under the Virus Research and Diagnostic Laboratories scheme, which includes 154 BSL-2 and 11 BSL-3 labs aimed at epidemic preparedness.
Q1. What is a BSL-4 laboratory?
Answer: A BSL-4 laboratory is a high-containment facility designed to safely handle the most dangerous pathogens, providing advanced research capabilities for diagnostics, vaccines, and therapeutics.
Q2. Where is the first state-funded BSL-4 lab in India located?
Answer: The first state-funded BSL-4 lab in India is located in Gandhinagar, Gujarat, and aims to enhance the country's health security and bio-preparedness.
Q3. How does the BSL-4 lab contribute to outbreak response?
Answer: The BSL-4 lab enables rapid research and response to outbreaks of deadly diseases, enhancing the country's ability to develop vaccines and treatments for infectious pathogens.
Q4. What role does the Gujarat Biotechnology Research Centre play?
Answer: The Gujarat Biotechnology Research Centre will operate the BSL-4 laboratory, overseeing its research and ensuring adherence to safety standards and protocols.
Q5. How many BSL-4 labs are there in India?
Answer: Currently, India has one operational civilian BSL-4 laboratory, with the new facility in Gandhinagar set to become the second.
Kutos : AI Assistant!
